• Bafilomycin C1 in Lysosomal and Cardiac Research

  2026-10-09

  Bafilomycin C1 is commonly described as a vacuolar H+-ATPases inhibitor for studying lysosomal acidification, autophagy, and intracellular trafficking. This overview separates supplier information from peer-reviewed evidence and examines how lysosomal perturbation could be interpreted in high-content cardiotoxicity research without treating indirect findings as proof of compound-specific effects.

• RNA Pol II Inhibition and Active Cell Death Signaling

  2026-10-09

  Harper et al. show that RNA polymerase II inhibition can trigger apoptosis through active signaling rather than passive loss of transcription-dependent gene products. The study identifies loss of hypophosphorylated RNA Pol IIA and defines a Pol II degradation-dependent apoptotic response, providing a framework for interpreting transcription-targeting therapies in cancer research.

• From Surface Labeling to Spatial Proteome Maps

  2026-10-08

  Spatial proteomics is moving beyond isolated markers toward cell-type-resolved molecular maps of intact tissue. This thought-leadership article examines how membrane-restricted tyramide chemistry can support that transition, what the 2025 PSPro study demonstrates, and where Biotin-XX Tyramide Reagent fits—without confusing conceptual relevance with direct validation.

• DDIT4 Links Microplastics to Kidney Organoid Injury

  2026-10-08

  A 2025 study used human pluripotent stem cell-derived kidney organoids to examine how 1 μm polystyrene microplastics affect nephron development. The findings connect organoid injury with DDIT4-associated mTOR suppression, autophagy, and apoptosis, while also highlighting the limits of translating an organoid model into environmental or clinical risk estimates.

• Sodium Picosulfate and the Gut–Brain Axis

  2026-10-07

  A translational perspective on Sodium Picosulfate as a defined gastrointestinal perturbation for studying motility, electrolyte handling, microbiota, and neuroinflammation—while distinguishing supplier evidence from findings reported in a rat hepatic encephalopathy imaging study.

• CFDA SE Cell Tracer Kit Overview

  2026-10-07

  The CFDA SE Cell Tracer Kit (SKU K1023) is an APExBIO product containing carboxyfluorescein diacetate succinimidyl ester for supplier-described fluorescent cell labeling and conceptual applications in cell lineage tracing and cell proliferation studies. No matched paper evidence or independent performance data were provided.

• LmPLK1 in Locust Gut Growth and Molting

  2026-10-06

  The reference study characterizes LmPLK1 as a regulator connecting cell-cycle activity in the locust midgut with tissue maintenance, molting, and 20-hydroxyecdysone signaling. Its RNA-interference findings support LmPLK1 as a biologically important pest-control target, although the evidence remains species-specific and requires further validation beyond the reported study system.

• Direct Mouse Genotyping Kit Plus: From Genotype to Evidence

  2026-10-06

  The Direct Mouse Genotyping Kit Plus can simplify genotype confirmation in mouse disease models through direct lysate PCR and a PCR master mix with dye reagents. This article examines its scientific role in protecting model validity, using recent SCA3/MJD neuromodulation research to distinguish genotyping evidence from mechanistic conclusions.

• CCCP in Mitochondrial Research: Evidence and Limits

  2026-10-05

  CCCP, or carbonyl cyanide m-chlorophenyl hydrazine, is best understood as a mechanistic perturbation tool for studying proton motive force and oxidative phosphorylation rather than as a disease-specific reagent. This overview compares the mechanistic rationale for CCCP with findings from a 2025 study using urine-derived stem-cell mitochondrial morphology and deep learning to investigate Alzheimer’s disease, while distinguishing reported evidence from proposed applications and highlighting limits on clinical interpretation.

• Fluoxetine HCl and the Motivation Circuit

  2026-10-05

  Fluoxetine HCl is more than a serotonin transporter probe. When paired with developmental models and reward-focused behavioral readouts, it can help translational researchers distinguish serotonergic signaling, motivation, and downstream mu opioid circuit adaptations.

• Erastin Through the Lens of Cell Death Evidence

  2026-10-04

  Erastin is a widely used ferroptosis inducer for studying redox collapse in genetically defined tumor models. This article offers a cross-pathway framework that distinguishes ferroptosis from necroptosis and explains what the Liu et al. viral-immunity study contributes to cancer biology research.

• Oncostatin M in Fibrosis Research: Evidence and Limits

  2026-10-03

  Recombinant Human Oncostatin M is a context-dependent cytokine research tool with reported effects on fibroblast proliferation and cytokine release. Current supplied evidence supports a mast cell–tryptase–PAR2 mechanism in experimental peritoneal fibrosis, but does not directly establish a role for OSM in that pathway or support clinical extrapolation.

• Lipo3K Transfection Reagent for ASO Assays

  2026-10-02

  Discover how the Lipo3K Transfection Reagent can support controlled nucleic acid delivery in gene expression studies and RNA interference research. This guide connects lipid-mediated uptake with pH-responsive antisense oligonucleotide design, emphasizing assay controls, interpretation, and practical optimization.

• Erastin: Designing Better Ferroptosis Assays

  2026-10-01

  Erastin is a benchmark ferroptosis inducer for studying redox collapse in RAS/BRAF-associated cancer models. This article presents an assay-design framework that connects Erastin perturbation with acidic tumor biology, iron mobilization, lipid peroxidation, and radiation-response experiments.

• IWR-1-endo: Wnt Signaling Inhibitor Workflows

  2026-10-01

  Build reproducible Wnt/β-catenin experiments with IWR-1-endo, from DMSO stock preparation and dose–response design to orthogonal pathway and morphology readouts. The workflow also adapts high-content profiling concepts from cardiomyopathy research to strengthen colorectal cancer, stem-cell, and regeneration assays.

8069 records 1/538 page Next 12345 下5页 Last page